中文久久乱码一区二区_在线a毛片_在线观看91视频_久久av综合网_久久九九网_99国产亚洲精品美女久久久久

Founded in 2005, Coben Group was designed and built according to GMP standard with a total area of 100,000㎡, a member of WZ Group-Global Fortune 500, Ranked No.270 in 2018.

Coben is specialized in developing and manufacturing of APIs and intermediates for various drugs. Main products include: Sofosbuvir, Tenofovir, Ticagrelor, Sacubitril, Voriconazole, Oseltamivir, Tranexamic Acid, Apremilast, Valsartan and their intermediates.

Coben is hi-tech enterprises, owning provincial R&D center. Most of the products are self-developed. We hold national and international patents for many product. Our factory is full equipped, including more than three hundred 500-5000L glass-lined and stainless steel reactors, with a total capacity of 600m³. We have industrial production for some difficultly operating reactions and procedures, including: butylithium reaction, Grignard reaction, hydrogenation reaction, low temperature reaction (-80°C), high pressure reaction (1-5Mpa), high vacuum distillation (=0.5mmHg), etc. Our company also pays high attention to manufacturing and contract manufacturing.

When developing the world's leading drugs, Coben has established complete quality assurance system which complies GMP standard. We have detection system, including Agilent HPLC, GC, UV, etc, and experienced quality management team, and have three API production workshops which according to the GMP standard. Some products already got GMP certificate.

Coben pays great attention to environmental protection, safety and sanitation, insists on safety first, clean production, and humanity. We are continuously improving employee's salary, welfare, working and living environment.

Base on the enterprise aim of "Reciprocate the masses, benefit the society", and the business philosophy of "Innovation, Characteristics, Quality", Coben will continue to provide high quality products, most competitive prices and good service to customers all over the world. We sincerely hope to establish stable and strategic business relationship with good enterprises at home and abroad.